Matrix metalloproteinase–activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity

Matrix metalloproteinase (MMP)–activated prodrugs were formed by coupling MMP-cleavable peptides to doxorubicin. The resulting conjugates were excellent in vitro substrates for MMP-2, -9, and -14. HT1080, a fibrosarcoma cell line, was used as a model system to test these prodrugs because these cells...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular cancer therapeutics 2005-05, Vol.4 (5), p.751-760
Hauptverfasser: Albright, Charles F, Graciani, Nilsa, Han, Wei, Yue, Eddy, Stein, Ross, Lai, Zhihong, Diamond, Melody, Dowling, Randine, Grimminger, Lisa, Zhang, Shu-Yun, Behrens, Davette, Musselman, Amy, Bruckner, Robert, Zhang, Mingzhu, Jiang, Xiang, Hu, Daniel, Higley, Anne, Dimeo, Susan, Rafalski, Maria, Mandlekar, Sandya, Car, Bruce, Yeleswaram, Swamy, Stern, Andrew, Copeland, Robert A, Combs, Andrew, Seitz, Steve P, Trainor, George L, Taub, Rebecca, Huang, Pearl, Oliff, Allen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!